At a glance
ClinicalIndex Comparison RecordN/ACompleted· 147 enrolled
Drug / intervention
Cross-Seal Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cross-SealTM IDE Trial: Prospective, Multi-Center, Single Arm Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System
In Brief
A clinical study evaluating Cross-Seal System for Vascular Closure. Completed, enrolled 147 participants across 20 sites.
Detailed Summary
This study evaluates the safety and effectiveness of the Cross-Seal vascular closure device in gaining post procedure hemostasis in subjects undergoing interventional procedures requiring an 8 to 18 french size introducer sheath.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVascular Closure
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 2018
Enrollment StartAug 2019
Primary CompletionMar 2021
TodayJul 2026
First PostedNov 28, 2018
Enrollment StartAug 9, 2019
Primary CompletionMar 22, 2021
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 7.6 years ago
Interventions
Cross-Seal Systemdevice
Use of the Cross-Seal system to close the femoral arteriotomy